These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 21999894)

  • 21. Botulinum toxin for the management of muscle overactivity and spasticity after stroke.
    Esquenazi A; Mayer N
    Curr Atheroscler Rep; 2001 Jul; 3(4):295-8. PubMed ID: 11389794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity.
    Kaku M; Simpson DM
    Drug Des Devel Ther; 2016; 10():1085-99. PubMed ID: 27022247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity.
    Chen JJ; Wu YN; Huang SC; Lee HM; Wang YL
    Arch Phys Med Rehabil; 2005 Aug; 86(8):1655-60. PubMed ID: 16084822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
    Turkel CC; Bowen B; Liu J; Brin MF
    Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.
    Ashford S; Turner-Stokes L
    Physiother Res Int; 2013 Sep; 18(3):178-89. PubMed ID: 23630050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of long-term, poststroke, upper-limb spasticity with onabotulinumtoxinA.
    Patel AT
    Phys Ther; 2011 Nov; 91(11):1636-41. PubMed ID: 21868610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
    Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
    Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin for the management of adult patients with upper motor neuron syndrome.
    Esquenazi A; Mayer NH; Elia AE; Albanese A
    Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
    Brashear A; McAfee AL; Kuhn ER; Fyffe J
    Arch Phys Med Rehabil; 2004 May; 85(5):705-9. PubMed ID: 15129392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spasticity must be treated by botulinum toxin with rehabilitaiton].
    Masakado Y
    Rinsho Shinkeigaku; 2013; 23(11):1261-3. PubMed ID: 24291950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
    Kanovský P; Slawek J; Denes Z; Platz T; Sassin I; Comes G; Grafe S
    Clin Neuropharmacol; 2009; 32(5):259-65. PubMed ID: 19644361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The efficacy of botulinum toxin therapy in patients with upper limb spasticity due to traumatic brain injury].
    Akulov MA; Hat'kova SE; Mokienko OA; Orlova OR; Usachev DY; Zakharov VO; Orlova AS; Tomskiy AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):30-35. PubMed ID: 27635608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin therapy for spasticity].
    Masakado Y
    Brain Nerve; 2014 Sep; 66(9):1039-47. PubMed ID: 25200575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors.
    Franceschini M; Iocco M; Molteni F; Santamato A; Smania N;
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):525-33. PubMed ID: 24963604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size.
    Cousins E; Ward A; Roffe C; Rimington L; Pandyan A
    Clin Rehabil; 2010 Jun; 24(6):501-13. PubMed ID: 20483887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of Botulinum Toxin for Lower Limbs Spasticity after Stroke: A Systematic Review and Meta-Analysis.
    Wu T; Li JH; Song HX; Dong Y
    Top Stroke Rehabil; 2016 Jun; 23(3):217-23. PubMed ID: 27077980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
    Turner-Stokes L; Ashford S
    Disabil Rehabil; 2007 Dec; 29(23):1806-12. PubMed ID: 18033605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.